Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

August 4, 2021

Study Completion Date

September 8, 2022

Conditions
Endobronchial MetastasesBronchoesophageal FistulaGeneral Anesthetic Drug Adverse Reaction
Interventions
DRUG

Remimazolam

Remimazolam is a new drug innovation in anesthesia. It combines the properties of two unique drugs already established in anesthesia - Midazolam and remifentanil. It acts on GABA receptors like midazolam and has organ-independent metabolism like remifentanil.

DRUG

Propofol

Propofol is used to put you to sleep and keep you asleep during general anesthesia for surgery or other medical procedures.

DRUG

Rocuronium

Rocuronium is a non-depolarizing neuromuscular blocker

DRUG

Remifentanil

Remifentanil is an esterase-metabolized opioid

DRUG

oxycodone

Oxycodone is an opiate painkiller.

DRUG

Sugammadex Sodium

Sugammadex sodium is an organic sodium salt that is the octasodium salt of sugammadex. Used for reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults undergoing surgery

DRUG

Flumazenil

Flumazenil is used to reverse the effects of a benzodiazepine

Trial Locations (1)

Unknown

Zhejiang Cancer Hospital, Hanzhou

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER

NCT05468671 - Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy | Biotech Hunter | Biotech Hunter